Superoxide reductases (SORs) are metalloproteins which constitute the most recently identified oxygen-detoxification system in anaerobic and microaerobic bacteria and archaea. SORs are involved in scavenging superoxide radicals from the cell by catalyzing the reduction of superoxide (O À 2 ) to hydrogen peroxide and are characterized by a catalytic nonhaem iron centre coordinated by four histidine ligands and one cysteine ligand. Ignicoccus hospitalis, a hyperthermophilic crenarchaeon, is known to have a neelaredoxin-type SOR that keeps toxic oxygen species levels under control. Blue crystals of recombinant I. hospitalis oxidized neelaredoxin (14.1 kDa, 124 residues) were obtained. These crystals diffracted to 2.4 Å resolution in-house at room temperature and belonged to the hexagonal space group P6 2 22 or P6 4 22, with unit-cell parameters a = b = 108, c = 64 Å . Cell-content analysis indicated the presence of one monomer in the asymmetric unit.
Introduction
All lifeforms require protection mechanisms against reactive oxygen species, which are produced upon the partial reduction of molecular oxygen. Furthermore, oxygen in itself is also toxic to anaerobic organisms. The superoxide anion (O À 2 ) is one of the reactive oxygen species that are formed upon one-electron reduction of O 2 and in many organisms is detoxified by superoxide dismutases (SODs), which couple the oxidation and reduction of superoxide anion (McCord & Fridovich, 1969) ,
Superoxide reductases (SORs) constitute a new family of enzymes that are able to scavenge superoxide anion through its reduction only (2) (Jenney et al., 1999; Pinto et al., 2010) , which distinguishes them from the SODs. Superoxide reductases have so far only been found in anaerobic and microaerobic organisms. SORs can be classified as 1Fe-SORs (or neelaredoxins) or 2Fe-SORs (or desulfoferrodoxins) according to the number of metal centres. Both share a common active site in which the reduction of superoxide anion occurs. This site is composed of a pentacoordinated iron with four equatorial histidine imidazoles and one axial cysteine sulfur in a square-pyramidal geometry [Fe(Cys)(His) 4 ]. In the oxidized state, and in most SORs, a glutamate residue near the iron centre is coordinated to the other axial position of the iron, resulting in an octahedral geometry. In the reduced state the glutamate residue no longer coordinates to the iron, allowing O À 2 to bind (Pinto et al., 2010) . The active-site-containing domain adopts a seven-stranded -barrel immunoglobin-like fold. In 2Fe-SORs this -barrel domain is linked by a loop to an N-terminal domain containing a second iron centre: a desulforedoxin-like centre, i.e. an Fe atom coordinated by four cysteine sulfurs in a distorted tetrahedral geometry [Fe(Cys) 4 ] 3+ (Archer et al., 1995; Coelho et al., 1997) . The function of this additional iron centre has still not been clarified but it is known not to be crucial for superoxide reduction. Interestingly, this extra N-terminal domain was also found in Treponema pallidum SOR, which lacks the cysteine motif for iron binding (Pereira et al., 2007) .
Ignicoccus hospitalis, a chemolithoautotrophic and hyperthermophilic crenarchaeon isolated from a submarine hydrothermal system at the Kolbeinsey Ridge (north of Iceland), is the only organism known to date that is capable of acting as a host for Nanoarchaeum equitans, the only cultivated member of the Nanoarchaeota (Paper et al., 2007; Huber et al., 2000) . The SOR protein encoded in the I. hospitalis genome is a 1Fe-SOR (Ih Nlr) and its amino-acid sequence shows the 'conserved' motif E 23 KHVP 27 , apart from the lysine and valine residues shown in bold, which are both replaced by threonine residues (Podar et al., 2008) . The positively charged aminoacid lysine, which was thought to be conserved, has been proposed to play a key role in the catalytic cycle of superoxide reduction, namely by attracting the anionic substrate and creating a positively charged surface around the catalytic site (Lombard et al., 2001) . The absence of this lysine residue in I. hospitalis SOR is relevant to understanding its role in the catalytic reaction and discriminating the essential amino-acid residues for superoxide reduction.
In this study, we describe the cloning, purification, crystallization and preliminary X-ray crystallographic analysis of the 1Fe-SOR from I. hospitalis. Its crystal structure will contribute to clarification of the superoxide-reduction mechanism.
Experimental procedures and results

Cloning and protein overproduction
Amplification of the complete nlr gene sequence (375 bp) encoding the neelaredoxin from I. hospitalis was achieved by PCR using genomic DNA of I. hospitalis and primers 5 0 -GAG GAC ACG GAC GAG CAT ATG AAG AG-3 0 (including an NdeI restriction site) and 5 0 -GAG GGA GAA CGA AGC TTT TTC CTT TC-3 0 (including a HindIII restriction site). The DNA fragment obtained was then cloned into the vector pET24a (+) (Novagen), transformed first into Escherichia coli XL2Blue cells. After sequencing to confirm the absence of unwanted mutations, the recombinant plasmid was transferred into E. coli strain BL21 (DE3) Gold. The cells were grown aerobically at 310 K in M9 minimal medium (da Costa et al., 2003) supplemented with 30 mg ml À1 kanamycin and enriched with 200 mM FeSO 4 Á7H 2 O until the OD 600 nm reached 0.3. At this stage, 400 mM isopropyl -d-1-thiogalactopyranoside was added, the temperature was lowered to 301 K and growth continued for 20 h. The cells were then harvested by centrifugation at 10 000g for 10 min at 277 K.
Purification
Harvested cells were resuspended in a buffer containing 20 mM Tris-HCl pH 7.6, 1 mM phenylmethanesulfonyl fluoride (PMSF) and 20 mg ml À1 DNase (Sigma), and broken in a minicell French press at 131 MPa. All subsequent purification steps were performed at pH 7.6 and 277 K. After centrifugation at 100 000g for 2 h, the soluble extract was dialyzed against 20 mM Tris-HCl and 1 mM PMSF (buffer A), heated at 333 K for 20 min and centrifuged at 7000g for 20 min. The soluble fraction was subsequently loaded onto a Q-Sepharose Fast Flow column (XK 26/10; GE Healthcare) previously equilibrated with buffer A. The fraction containing Ih Nlr eluted in the flowthrough; it was concentrated by ultrafiltration (Amicon, 10 kDa cutoff) and loaded onto a Superdex 75 column (XK 26/60; GE Healthcare) equilibrated with 20 mM Tris-HCl and 150 mM NaCl. The collected fractions were analyzed and judged to be pure on the basis of SDS-PAGE gels (Fig. 1) . The protein concentration and total iron content were determined using the bicinchoninic acid proteinassay kit (Pierce; Smith et al., 1985) and the 2,4,6-tripyridyl-S-triazine method (Fisher & Price, 1964) , respectively. Finally, the protein was concentrated to 15 mg ml À1 using a 10 kDa cutoff Centricon (Vivaspin). 
Crystallization and cryoprotection
Initial crystallization screening was performed using a protein concentration of 15 mg ml À1 in 20 mM Tris-HCl pH 7.2, 150 mM NaCl. Screening was carried out with the NeXtal/Qiagen Classics I screen using the sitting-drop vapour-diffusion method in a 96-well plate (Greiner) and a Cartesian Minibee nanolitre robot (Genomics Solutions). Three different drop ratios were prepared per condition screened, using 100:100 nl, 100:200 nl and 200:100 nl ratios of reservoir and protein solution. The drops were equilibrated against 100 ml reservoir solution. After 2 h equilibration, promising protein crystals were obtained from conditions 22 [0.1 M HEPES pH 7.5, 70%(v/v) MPD] and 82 [0.1 M Tris pH 8.5, 0.01 M NiCl 2 , 20%(v/v) PEG 2000 monomethyl ether]. The crystals from the first condition were light blue multiple plate-like crystals with a hexagonal shape, while those from the second condition were dark blue, single, thick and hexagonal bipyramid-shaped. Both conditions were manually reproduced and optimized in 24-well plates using the hanging-drop vapour-diffusion method and the best crystals were obtained from optimization of condition 82. Hexagonal bipyramid-shaped crystals with maximum dimensions of 350 Â 200 Â 200 mm were obtained using a crystallization solution consisting of 85 mM Tris pH 8.5, 8.5 mM NiCl 2 , 15%(v/v) PEG 2K MME and 15%(v/v) glycerol in drops composed of 2 ml protein and 0.5 ml reservoir solution (Fig. 2) . Owing to the high sensitivity of the Ih Nlr crystals to the most common cryoprotectants (e.g. glycerol, PEG 400 and ethylene glycol), eight different cryoprotectants were tested, but without success: 20% MPD, 1 M sodium malonate, 17.5% sucrose, 1 M ammonium sulfate, 17.5% 2-propanol, 3.5 M sodium nitrate and 2 M magnesium acetate.
Data collection and processing
Since no suitable cryoprotectant could be found, X-ray diffraction data were collected in-house at room temperature. One crystal was mounted on a MiTeGen MicroMount steel pin glued to a MiTeGen MicroRT capillary-mounting system. A 2.4 Å resolution diffraction data set was measured using a Bruker AXS Proteum Pt135 CCD detector system coupled to a Bruker AXS Microstar-I rotating-anode X-ray generator with Montel mirrors (see Fig. 3 ). The images were processed with SAINT and scaled with SADABS as part of the Bruker AXS PROTEUM software suite. The quality of the diffraction data was analyzed using XPREP (Bruker AXS) and a summary of the statistics is presented in Table 1 . Work is in progress towards establishing cryoconditions that will allow flash-cooled crystals to be measured at a synchrotron X-ray source in order to obtain a data set to the highest possible resolution.
Figure 3
Diffraction image of an I. hospitalis neelaredoxin crystal collected in-house at room temperature. 
